Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.45 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13403904 | 0.83 | CYP1A2 (0.58) | CYP1A2CYP2C9ALDH1A1CYP2D6CYP2C19 | |
| SCHEMBL21325281 | 0.79 | CYP1A2 (0.62) | CYP1A2CYP2C9ALDH1A1CYP2D6CYP2C19 | |
| SCHEMBL22758462 | 0.77 | CYP1A2 (0.53) | CYP1A2CYP2C9ALDH1A1CYP2D6CYP2C19 | |
| SCHEMBL17173116 | 0.77 | CYP1A2 (0.52) | CYP1A2CYP2C9ALDH1A1CYP2D6CYP2C19 | |
| SCHEMBL17173113 | 0.77 | CYP1A2 (0.52) | CYP1A2CYP2C9ALDH1A1CYP2D6CYP2C19 | |
| SCHEMBL24568676 | 0.75 | CYP1A2 (0.62) | CYP1A2CYP2C9ALDH1A1CYP2D6CYP2C19 | |
| SCHEMBL27425666 | 0.75 | CYP1A2 (0.54) | CYP1A2CYP2C9ALDH1A1CYP2D6CYP2C19 | |
| SCHEMBL28885160 | 0.75 | CYP1A2 (0.57) | CYP1A2CYP2C9ALDH1A1CYP2D6CYP2C19 | |
| SCHEMBL23464918 | 0.74 | — | — | |
| SCHEMBL26323336 | 0.74 | CYP1A2 (0.60) | CYP1A2CYP2C9ALDH1A1CYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023166076-A1 | COMBINATIONS OF CTPS1 AND BCL2 INHIBITORS FOR CANCER | STEP PHARMA S.A.S. (FR) | 2023-09-07 | — | — | WO | disclosed |
| WO-2023166080-A1 | COMBINATION TREATMENTS COMPRISING A CTPS1 INHIBITOR AND A WEE1 INHIBITOR | STEP PHARMA S.A.S. (FR) | 2023-09-07 | — | — | WO | disclosed |
| WO-2023166077-A1 | COMBINATION OF A CTPS1 INHIBITOR AND A ATR INHIBITOR IN CANCER THERAPY | STEP PHARMA S.A.S. (FR) | 2023-09-07 | — | — | WO | disclosed |
| WO-2020245664-A1 | N-(5-(6-ETHOXYPYRAZIN-2-YL)PYRIDIN-2-YL)-4-(2-(METHYLSULFONAMIDO)PYRIMIDIN-4-YL) TETRAHYDRO-2H-PYRAN-4-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS HUMAN CTPS1 INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES | STEP PHARMA S.A.S. (FR) | 2020-12-10 | — | — | WO | disclosed |